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Monitoring the Future (MTF) is a long-term study of American adolescents, college students, 
and adults through age 50. The study is supported under a series of investigator-initiated, 
competing research grants from the National Institute on Drug Abuse, and has been conducted 
annually by the University of Michigan’s Institute for Social Research since 1975. 
 
The present volume becomes the fourth monograph in MTF’s series of annual reports. The three 
other monographs are as follows: an Overview of Key Findings, published near the beginning of 
each year, which provides early findings on the levels and trends in use of various substances by 
the nation’s 8th-, 10th-, and 12th-grade students surveyed in the previous year.1 The much larger 
and more complete Volume I, published some months later, provides more detailed and complete 
findings on the same population.2 The third monograph, entitled Volume II, usually is available 
in the fall. It provides similar prevalence and trend information on the substance-using behaviors 
of adult high school graduates through age 50, based on a series of follow-up surveys by mail of 
representative samples of students from each high school graduating class.3 One important 
subgroup of the adults being surveyed annually in these follow-up surveys is college students, 
and Volume II provides findings specific to that population.  
 
The present volume is being published separately for the first time this year. Whereas the other 
three MTF monographs address the topic of substance use, the present volume focuses on a 
range of behaviors related to the spread of the human immunodeficiency virus (HIV) responsible 
for the acquired immunodeficiency syndrome (AIDS). The population under study is young adult 
high school graduates ages 21–30 in the general population. Previously, findings on this subject 
were presented as a final chapter in Volume II based on measures of HIV/AIDS risk and 
protective behaviors that were introduced into the MTF follow-up studies in 2004. However, as 
the content expanded considerably and the historical period lengthened, a separate volume on 












Since the early 1980s, the spread of HIV/AIDS has become a serious public health concern. 
Some of the behaviors that put people at heightened risk of contracting and spreading HIV are 
connected to drug abuse—in particular, drug use by injection when it involves needle sharing. 
Another behavior related to heightened risk is having multiple sex partners, which itself is a 
behavior correlated with drug use. Further, both drug use and having multiple sex partners tend 
to be more prevalent among young adults than other age groups.2,3,4,5,6 
 
A considerable literature has evolved based on studies of high-risk populations, such as men who 
have sex with men, but there are fewer studies of these behaviors as they occur in the general 
population. Currently, to our knowledge, there are five data collection efforts in addition to the 
present one that provide some information on HIV/AIDS risk behaviors based on nationally 
representative surveys of the general population. Each of these surveys provides some key 
HIV/AIDS risk behavior data; however, as discussed below, none fully duplicates the type of 
HIV/AIDS-related information that can be produced by the MTF study. 
 
National Longitudinal Study of Adolescent Health (Add Health). The Add Health study is a 
nationally representative, longitudinal study of U.S. youth who were in grades 7–12 during the 
1994–1995 school year. This set of class cohorts has been followed into adulthood, with 
additional data collection waves in 1996, 2001/2002, and 2007/2008.7 Collected data include 
measures on perceived risk of HIV/AIDS, sexual behavior history, contraceptive use, sexually 
transmitted disease (STD) history, and substance use including injection drug use (IDU) and 
needle sharing. Not all of the HIV/AIDS risk behavior measures are asked at each wave of data 
collection. Analyses published with Add Health data have shown important racial/ethnic 
differences in contraceptive use (including condom use) and number of sexual partners,8 
prevalence rates of STDs and HIV infections, as well as sexual behavior and substance use 
patterns.9,10,11 It also has shown relationships between chronic depression and having multiple 
sexual partners.12 Important sociodemographic differences in self-reported HIV testing have also 
been found.13 The Add Health study follows one set of six adjacent class cohorts, in contrast to 
MTF, which continually adds cohorts and can thus track historical trends for fixed age groups 
and for various cohorts over the years. 
 
General Social Survey (GSS). Conducted by the National Opinion Research Center at the 
University of Chicago, GSS began in 1972 as an annual survey (although no surveys were 
conducted in 1979, 1981, or 1992) and went to a biennial format beginning in 1994. Prior to 
2008, the study used cross-sectional surveys of the U.S. adult household population (ages 18 and 
over). Starting in 2008, the design was changed to a rotating panel, with each entering cohort to 
be followed up for the next two consecutive surveys (in 2008, the 2006 respondents were re-
interviewed, and will be interviewed again for the final time in 2010).14 However, the HIV/AIDS 
risk behaviors are not included in the panel re-interviews. The majority of GSS data is obtained 
using face-to-face interviewing; in 2002, it switched to computer-assisted personal interviewing 
(CAPI). As part of the CAPI format the respondent is handed the interviewer’s laptop computer 
to self-complete the more sensitive sections. Because MTF uses self-administered, mailed 
questionnaires, a higher level of perceived privacy may exist for respondents when answering 
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HIV/AIDS risk behavior–related items. Items on sexual risk and protective factors began to be 
added to the GSS starting in 1988, and now include measures such as number and type of sex 
partners, ever paying for sex, heterosexual and homosexual sex, condom use, and HIV/AIDS 
testing. A limited number of substance use items are asked, including injection drug use (but not 
needle sharing) and crack cocaine use (both asking about lifetime and past 30 days). However, 
the only other item on substance use (use of any illegal drugs in the past 12 months) has not been 
asked since 2004.15 The majority of HIV/AIDS publications from the GSS have reported on 
sexual risk behaviors.16,17,18,19 Given that substance use behaviors are not consistently collected in 
the GSS, and needle sharing is not measured, MTF provides an important additional source for 
data that looks at the intersection of these behaviors with other HIV/AIDS risk and protective 
factors. MTF also includes the collection of panel data on both risk and protective behaviors. 
 
National Survey on Drug Use and Health (NSDUH). Begun in 1971, the NSDUH study is now 
an annual, cross-sectional survey of the civilian, noninstitutionalized U.S. population ages 12 and 
older.20 In 1999, NSDUH was redesigned to allow state-level estimates. As suggested by the 
study name, the focus is on measures related to substance use, including injection drug use 
(IDU).21,22 Published findings utilizing NSDUH data related to IDU have reported national IDU 
prevalence levels, as well as important demographic and geographic variation in such use.23 Data 
are also collected on lifetime and past-year HIV/AIDS diagnoses, as well as related health 
conditions such as hepatitis and sexually transmitted diseases. However, data on participation in 
high-risk sexual behaviors, as well as behaviors such as needle-sharing, are not collected; which 
distinguishes NSDUH from MTF. Also, MTF collects longitudinal data on individuals over time 
as part of its cohort-sequential design, while NSDUH collects only cross-sectional data. 
 
National Survey of Family Growth (NSFG). Sponsored by the National Center for Health 
Statistics, NSFG was begun in 1973 and was initially designed to be a national U.S. fertility 
study, with only female respondents. Beginning in 2002 (Cycle 6), the survey provided 
nationally representative cross-sectional samples of both males and females ages 15–44. In mid-
2006, the NSFG began continuous interviewing utilizing a rolling, cumulating yearly nationally 
representative sample of U.S. households (Cycle 7, which ends in 2009).24 The latest cycle 
gathers detailed data on sexual risk behaviors of many kinds, including number of sex partners 
and condom use, differentiating by age and race/ethnicity,25 other sociodemographic differences 
in heterosexual anal and oral sex,26 and sexual health risks and formal sex education.27 
Homosexual sex is also detailed in the interviews. The NSFG contains some items on substance 
use, including a lifetime measure of needle sharing; it also contains diagnoses of sexually 
transmitted diseases related to HIV/AIDS risk behaviors. The procedure for gathering 
information on these highly sensitive and detailed sexual behaviors is audio computer-assisted 
self-interviewing (A-CASI). In this procedure, the interviewer is aware of neither the highly 
sensitive questions as they are asked nor the answers being given, thus providing respondents 
with a high level of privacy. MTF uses self-administered, mailed questionnaires, which should 
also provide respondents with a high level of privacy. Like NSDUH, longitudinal panel data are 
not collected on respondents in NSFG. MTF does have relevant prior and subsequent data from 
the respondents in its panels, including HIV/AIDS risk and protective behaviors from age 21 into 
later time points. 
 
National Youth Risk Behavior Survey (YRBS). YRBS is conducted every two years, and provides 
nationally representative, cross-sectional data on priority health risk behaviors for 9th- through 
3





12th-grade students in public and private U.S. schools.28 Several HIV/AIDS-related risk 
behaviors have been measured since its inception in 1991, including substance use and sexual 
activity. Published YRBS data include national and sociodemographic group-specific prevalence 
measures of high school student licit and illicit substance use (including a measure of lifetime 
intravenous drug use), lifetime and current sexual activity (including number of partners), 
condom use, substance use before sexual behavior, and HIV/AIDs education and testing.29,30 
YRBS data have been used to examine trends over time in such behaviors,31,32 as well as how 
substance use and sexual risk behaviors interrelate.33,34 The work of MTF complements that of 
the YRBS by adding respondents ages 21 to 30, a highly relevant age group for the spread of 
HIV/AIDS. It also contains a more complete set of drug use measures, including annual and 30-
day injection drug use. In addition, the longitudinal nature of MTF allows an examination of how 
HIV/AIDS risk behaviors change over time within age groups and within cohorts. 
 
A review of these five studies shows that, although key data are provided by each, none of the 
studies allows for the ongoing, cohort-sequential prospective examination of both substance use 
and other risk and protective behaviors for HIV/AIDS among the U.S. young adult population. 
YRBS does not cover the same age group; GSS does not broadly examine substance use 
behaviors, nor does it include the HIV/AIDS risk and protective behaviors in its panels; NSDUH 
does not cover sexual behaviors; Add Health covers only six class cohorts; NSFG has longer 
time cycles and, like YRBS and NSDUH, does not gather panel data on its subjects. Further, 
most of these studies do not duplicate all of the measures of risk and protective behaviors 
covered in MTF. Whatever changes occur in the proportions of American young adults choosing 
to engage in these risk and risk-reduction behaviors will, of course, have very important 
consequences for the course of the nation’s HIV/AIDS epidemic, which is why MTF findings 
stand to make important contributions to our understanding of this major health problem and our 










As has been illustrated, MTF is uniquely suited to address key gaps in the literature concerning 
HIV/AIDS-related risk and protective behaviors. Most of the features that make MTF an 
important epidemiologic and etiologic study of drug use also apply to tracking and studying 
HIV/AIDS-related behaviors: it is population-based, prospective, cohort-sequential, and has 
especially rich measures of drug use with which to study how drug use relates directly (through 
IDU) and indirectly (through engaging in risky sex while high) to HIV transmission. 
 
The MTF research design is described in detail in both Volume I and Volume II, so we limit the 
description here to a brief overview. 
 
Samples 
The panels under study here were all drawn from participants in the MTF follow-up surveys of 
21- to 30-year-olds in 2004–2008, representing graduates from the classes of 1992 through 2005. 
 
The MTF design has included a representative subsample of each 12th-grade class sample since 
1976, with 2,400 cases from each class selected for follow-up. The 2,400 are randomly split into 
two half samples, one followed up on even numbered years and the other followed on odd 
numbered years. With this design, it is possible to present data for each class every year while 
surveying each respondent only every other year, which was judged to be less demanding and, 
therefore, more conducive to retention in the panels. In order to ensure sufficient numbers of 
drug users in these panels, those 12th graders reporting 20 or more occasions of marijuana use in 
the prior 30 days (i.e., “daily users”) or any use of other illicit drugs in the prior 30 days are 
selected with a higher probability (by a factor of 3.0) than the remaining 12th graders. 
Differential weighting is then used in all subsequent analyses to compensate for these differential 
sampling probabilities. Because those in the drug-using stratum receive a weight of .33 in the 
calculation of all statistics to correct for their overrepresentation in the selection stage, there are 
more follow-up respondents than are reported in the weighted Ns given in the tables. 
 
The two half samples from each cohort are followed biennially until they reach age 29 or 30. 
After that, they are followed at five-year intervals, starting at age 35, currently up to age 50. The 
present monograph focuses on respondents ages 21 to 30. Future editions will include later ages 
as the numbers of cases become sufficiently large for meaningful analysis. 
 
Measures 
Each 12th-grade sample in recent years has been administered six different questionnaire 
forms—a procedure adopted in order to cover more material than would have been possible 
using a single form. In the follow-up surveys, each individual receives the same form as the one 
completed in 12th grade, though some content is replaced with more age-appropriate topics such 
as family formation, higher educational experiences, and work history. In 2004, new questions 
covering risk and protective behaviors for HIV/AIDS were inserted into two of the questionnaire 
forms being mailed to people of modal ages 21–30. Risk behavior variables include lifetime and 
12-month frequency of injecting drugs without a doctor’s order; lifetime and 12-month 
prevalence of using a needle that respondents “knew (or suspected) had been used by someone 
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else” before they used it; number of sex partners the respondent had during the 12 months prior 
to the survey; and whether those partners had been exclusively opposite sex, same sex, or both 
male and female. Protective behaviors include lifetime and 12-month prevalence of being tested 
for HIV, obtaining the results of the most recent HIV test, and frequency of condom use in the 
prior 12 months. We also ask about lifetime and 12-month prevalence of donating blood or blood 
plasma. The exact questions measuring these different variables are included in the tables at the 
end of this monograph. 
 
One reason for limiting the new HIV/AIDS-related questions to two forms was to determine 
whether the inclusion of these sensitive items would adversely affect response rates. Fortunately, 
no decrement was observed, so the same set of questions was added to an additional form in the 
2007 survey, raising the case count by half from what it had been in 2004–2006*. 
 
Field Procedures 
The initial data collection from panel members occurs at 12th grade; they complete a self-
administered questionnaire in a group setting, usually their normal classroom but sometimes in 
larger groups. They are asked to complete the questionnaires during a usual class period (about 
45 minutes) and to complete a tear-off card providing contact information, which permits 
subsequent communication with the subsample selected for panel study follow-up. After the card 
is separated from the questionnaire, the identifying information on it can only be matched to the 
questionnaire using a computer file at the University of Michigan, because the numbers printed 
on the back of the questionnaire and the card are randomly matched numbers. This, plus the fact 
that the questionnaires are administered, and the cards are collected, separately by a field 
representative from the University of Michigan, seems to assure most respondents that their 
confidentiality has been protected. (The 2,400 selected for follow-up comprise about 15% of the 
approximately 16,000 seniors surveyed.) 
 
The respondents subsequently selected into the panels are followed by mail—a highly cost-
effective mechanism. They receive MTF newsletters each year with address correction cards 
enclosed, and invitation letters—the first of which comes separately from the questionnaire, 
while subsequent letters are printed on the front of the questionnaire. Each questionnaire is sent 
with a check made out to the subject, currently in the amount of $20. Reminder postcards are 




We discuss here the nature of the panel attrition problem generally, the response rates for MTF 
panel surveys in recent years, and evidence relevant to assessing the impact of attrition on the 
study’s research results. 
 
Response Rates. Virtually all longitudinal studies of drug use—including MTF—experience 
attrition, which is often differential with respect to substance use.35 In addition, survey 
 
*When we added this new form to the set containing questions on risk and protective behaviors for the transmission of HIV, we compared its 
results with those from the other two forms to make sure that there was not a systematic difference among them. The results proved highly 
comparable across forms, which is reassuring for trend estimation based on an increasing number of forms used. 
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response rates in general have been declining over the past few decades,36,37 highlighting an 
important challenge in the conduct of all population-based research. 
 
A vital feature of the MTF panel studies is their very low cost per respondent. There are many 
advantages to collecting panel data through low-cost mail surveys. Indeed, given the number of 
questionnaires sent each year (roughly 18,000) across the entire coterminous U.S., using low-
cost mail surveys is our best (and really only) cost-effective option. One disadvantage of this 
mode of data collection is that attrition rates tend to be higher than those that might be obtained 
with much more expensive methods, such as intensive personal tracking and interviewing. 
Certainly there exist a few large epidemiological/etiological surveys that have better retention 
rates, but their procedures are extremely expensive and not realistic for an ongoing effort like 
MTF. Nevertheless, our retention rates compare favorably with those of most longitudinal 
studies reported in the field, including interview studies. 
 
Retention rates in the biennial follow-ups of respondents modal ages 19–30 (corresponding to 
the first six follow-ups) decline with the length of the follow-up interval. For the five surveys 
from 2004 to 2008, the response rate in the first follow-up (corresponding to one to two years 
past high school) averaged 56%, and for the second through sixth follow-ups (corresponding to 
3–12 years past high school) response rates averaged 52% of the originally selected panel. 
(Among long-term respondents—the 35-, 40-, 45-, and 50-year-olds—retention rates are quite 
good, apparently because some of the decline over time in retention rates reflects cohort 
differences.) In sum, the response rates attained under the current design range from respectable 
to quite good, especially when the low-cost nature of the procedure, the long time intervals 
involved, and the substantial length of the questionnaires are taken into account. More 
importantly, the evidence leaves us confident that the data resulting from these follow-up panels 
are reasonably accurate, which brings us to our adjustments for panel attrition and the 
comparison of our results with those from other sources. 
 
The Impact of Panel Attrition on Research Results. An important purpose of the MTF panel 
study is to allow estimation of drug prevalence rates among American high school graduates at 
various age levels. Thus, we have always been concerned about making the appropriate 
adjustments to account for panel attrition. In essence, our standard adjustment process is a 
poststratification procedure in which we reweight the data obtained from the follow-up samples 
so that their reweighted 12th-grade distribution on a given drug reproduces the original 
distribution of use observed for that drug based on all participating high school seniors. This 
procedure is carried out separately for cigarettes, alcohol, and marijuana, as well as other illicit 
drugs (combined). As expected, this produces prevalence estimates that are somewhat higher 
than those uncorrected for attrition, indicating a positive association between drug use and panel 
attrition. However, the adjustments are relatively modest, as documented next. 
 
One reason the adjustments are modest is that attrition rates do not differ greatly by levels of 
12th-grade substance use; they differ some, but less than one might expect. For example, among 
all respondents who had never used marijuana, an average of 79% of the classes of 1976–1998 
participated in the first follow-up. The proportion responding is somewhat lower among those 
who had used marijuana once or twice in the last 12 months (75%). This proportion decreases 
gradually with increasing levels of marijuana use; but even among those who used marijuana on 
20 or more occasions in the last 30 days in 12th grade, 67% participated in the first follow-up. 
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The corresponding participation rates for the same drug use strata at the fourth follow-up (i.e., at 
modal ages 25–26) were 66%, 63%, and 56%, respectively. Thus, even among those who were 
heavy users of marijuana in high school, response rates at the fourth follow-up were only 10 
percentage points lower than among those who had never used marijuana by 12th grade. That is 
not to say that we assume all types of drug users remain in the panels at comparably high rates. 
We believe that people who become dependent on or addicted to heroin or cocaine are unlikely 
to be retained in reasonable proportions. That is why we are careful not to quantify or 
characterize these special segments of the population. But we note that they constitute very low 
proportions of the adult population. 
 
The National Survey on Drug Use and Health (NSDUH) seems to provide the best available data 
against which to validate the estimates generated for adult age groups in MTF, because it is also 
based on national samples but uses cross-sectional surveys that do not carry the burden of panel 
attrition. Their results, of course, may be affected by their own nonresponse rates; but that will 
be true of any comparison survey. The overall response rate for NSDUH in 2006 was 74%. In 
some earlier analyses, we compared the prevalence rates on a set of drugs—cigarettes, alcohol, 
marijuana, and cocaine—for which there was reasonable similarity in question wording across 
the two studies. The comparisons that follow are for the age group 19–28 in the MTF panel data, 
and for 19–28 (or 19–29 for 1999 only) in the NSDUH cross-sectional data. We used the most 
recent readily available comparable data at that time—2004, but similar results are found in a 
number of prior years. Other things equal, NSDUH should have higher rates than MTF because 
it includes school dropouts. Nevertheless, MTF estimates for the 30-day prevalence of marijuana 
are actually higher (14.4% without poststratification and 16.5% with it) than the NSDUH 
estimate (14.0%). The same is true for the 12-month cocaine prevalence estimate (6.3% without 
poststratification and 7.1% with it, vs. 6.3% in the NSDUH estimate). The higher MTF estimates 
for both marijuana and cocaine suggest that attrition does not produce substantially lower 
estimates of drug use than would be obtained if response rates were higher. 
 
Even with attrition, substantial proportions of recent drug users remain in the MTF follow-up 
samples. In recent years, about 15–17% of 19- to 28-year-old respondents reported marijuana use 
in just the prior 30 days and about 5–7% reported past 12-month use of cocaine. These 
proportions and the underlying numbers of actual cases are quite adequate for analytic purposes. 
An important point worth emphasizing here is that in the MTF panel, attrition is not necessarily 
as great a problem as in a cross-sectional study, because we already know a great deal about each 
of the follow-up nonrespondents, including their substance use, based on a lengthy questionnaire 
in 12th grade (and, for many, in subsequent years as well). Thus, adjustments can be made 
utilizing data that are highly informative about the missing individuals. 
 
Effects on Relational Analyses. While differential attrition (uncorrected) may contribute to some 
bias in point estimates and other univariate statistics, such attrition tends to have less influence 
on bivariate and multivariate statistics. This has been found to be true in analyses of a variety of 








Sample Coverage. Of course, there are certain limitations to the present study for attempting to 
quantify HIV/AIDS-related risk and protective behaviors in the general population. Perhaps the 
major limitation derives from the sample under study, because MTF does not include the 15% or 
so of each high school class cohort that leaves school before graduation. So, although our 
coverage includes the great majority of the population of interest (young adults who recently 
entered their 20s), an important and on average somewhat more deviant segment of the 
population is not covered (high school dropouts). As we have said, panel attrition is a limitation; 
but techniques have been used here to help compensate for the effects of panel attrition, as will 
be described below. 
 
These limitations likely lower the estimates of risk behaviors from what their values would be if 
the entire population of 21- through 30-year-olds in the United States could be surveyed, but it is 
difficult to quantify by how much. (We believe that we do a better job of characterizing the 
original target population, which is high school graduates.) However, because the school dropout 
rates have changed little since MTF began, and panel retention rates tend to change very slowly, 
we believe that the trend estimates—which ultimately will be among the most important results 
for policy purposes—will be little affected by these omissions from the sample, particularly 
given our procedures for compensating for panel loss. 
 
Validity. Because of the sensitivity of some of these behaviors, one might reasonably ask about 
the validity of the data reported. Recognizing this, we provided an introduction to the section of 
the questionnaire dealing with HIV/AIDS risk and protective factors explaining why these 
questions are important in helping us to increase our understanding of the HIV/AIDS epidemic, 
re-emphasizing the protections of confidentiality by reminding respondents that their answers are 
never connected with their names, and inviting respondents to leave blank any questions that 
they “do not wish to answer.” The decrement in response rates between the preceding 
nonsensitive questions and those in this section was very small—on the order of about one 
percentage point for five questions, two percentage points for two questions, and just under three 
percentage points for one question—suggesting that the great majority of respondents felt willing 
and able to answer these questions. The question with a 3% decrement asked about the use of 
condoms. We believe that the slightly higher nonresponse rate may be due to high variability in 
use of condoms, making the question difficult to answer. Further, females having only female 
partners likely felt this question was not applicable to them, and they had a considerably higher 
than average missing data rate on this question. The question on needle sharing had the second 
highest increment in nonresponse (2.1 percentage points); however, most of that increment (1.2 
percentage points) is attributable to respondents who indicated no history of drug injection in the 
previous question, so simply skipping this question was a logical response for them. Thus the 
corrected increment in nonresponse for this question was also around one percentage point. 
 
Sample Sizes and Trend Estimation 
We have been collecting data on HIV/AIDS-related behaviors for five years, though much of the 
emphasis here is still on establishing the prevalence and, when available, the frequency of these 
behaviors in the general population, which we can now do for 2004–2008 combined. Having five 
years of data is valuable because of the low prevalence rate for some of these behaviors (in 
particular, for the intersection of some behaviors); the use of multiple years of data increases 
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estimate precision. Because the intersection of some of these behaviors is of particular 
importance, we report the bivariate associations among them, though the low numbers of cases 
still limit to some degree the conclusions that can be reached. Over time the case counts will 
continue to cumulate and allow more detailed analyses. 
 
For estimates based on one or two years of data, the number of cases or observations is 
equivalent to the number of different or distinct individuals surveyed. However, for estimates 
based on all years combined, the number of different individuals is lower than the number of 
cases or observations. This is because individuals are surveyed every two years, and therefore, 
some individuals contribute more than one questionnaire over time. Thus, for estimates using 
data from 2004 through 2008, a single individual could contribute one, two, or three 
questionnaires. The total number of weighted observations for 2004 through 2008 is 10,176, but 
the total number of unique individuals is 6,333. The weighted Ns reported in each table refer to 
observations and not individuals. 
 
It should be noted that we also examined the data for each of the five years separately to look for 
signs of change in prevalence levels, and did not find evidence of systematic trending in any of 
the risk or protective behaviors under study during this interval (as will be discussed below). It is 
encouraging, though, that the univariate distributions replicate quite well across years, which 
provides powerful evidence of estimate reliability. 
 
Adjusting for the Effects of Panel Attrition 
In chapter 3 of Volume II we described the procedures used to adjust the substance use estimates 
to eliminate (insofar as possible) the effects of panel attrition. In the case of substance use 
estimates, we have data on the prevalence and frequency of the same behaviors among all 
respondents at 12th grade. This permits a poststratification procedure in which we reweight the 
obtained follow-up samples such that the reweighted distribution of their senior-year responses 
reproduces the original distribution obtained from the entire 12th-grade sample for the behavior 
under consideration. 
 
However, measures of non-drug-using variables under consideration in this monograph were not 
included in the 12th-grade surveys, so that particular form of poststratification is unworkable. 
Instead, we have implemented a different poststratification reweighting procedure for the follow-
up respondents in which we attempt to correct for their differential retention in the panels as a 
function of demographic and other characteristics that were measured in 12th grade. For 
example, males have a somewhat lower retention rate than females, which means that their 
proportion in the attained follow-up sample is lower than it was in the original 12th-grade in-
school survey. We are able to correct for that difference by up-weighting the data from all males 
who did continue in the panel study, so that males will remain in the same proportion in the 
panel as they were when the panel was first selected. 
 
Using this strategy, we simultaneously correct for differential attrition using multiple variables 
identified as being related to attrition. To do so, we calculate the retention rate for the various 
cells defined by the intersection of these variables and then weight the respondents in each cell 
by the reciprocal of the retention rate found for people who belong in that cell. These 
adjustments generate a newly weighted panel with frequency distributions on the variables used 
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in this reweighting procedure (e.g., gender or grade point average in high school) that reproduce 
those of the original 12th-grade sample. As a practical matter, the number of variables used in 
this procedure must be limited to some extent by the total sample size, lest certain cells become 
too small to be reliably reweighted. 
 
The variables that we use for defining the cells are as follows: gender (male/female), ethnicity 
(White/non-White), grade point average in 12th grade (low/medium/high), and illicit drug use in 
12th grade (none/marijuana only/any other illicit drug). The first two variables were prespecified, 
while the latter two were chosen from a larger set entered into a regression analysis in which 
they emerged as the strongest predictors of retention rate. 
 
These four variables generate 36 nonoverlapping categories (or cells) of individuals that can be 
reweighted to correct for differential rates of attrition. Retention rates in each of the 36 cells are 
then calculated based on the number of people in each cell in the original panel and the number 
who subsequently provided data at the follow-up; the participating members of each cell are 
assigned a new weight that is the reciprocal of the retention rate—that is, one divided by the 
retention rate. (For example, if White males with low grades and illegal drug use other than 
marijuana are represented in the retained panel at a 50% retention rate, each of the respondents in 
that cell would be given a weight of two.) This new weight is then multiplied by a separate 
individual weight that corrects for any differential probability in being selected into the panel 
originally. 
 
With the resulting weight, we have a total weighted N (sample size) equal to the original panel 
size, not the actual retained panel, which means that we would be overstating the accuracy with 
which we are making prevalence estimates. Thus, in a final step, all individual weights are then 
multiplied by the overall sample retention rate to bring the weighted sum of cases down to the 
actual number of individually weighted cases still in the panel. This entire correction procedure 
was carried out separately for each of the five years (2004–2008). 
 
We consider this correction procedure to be appropriate in this circumstance, but we caution the 
reader that it is not possible to correct entirely for the effects of panel attrition for two reasons. 
First, specific to our relatively small sample for these measures, we cannot adjust for all 
measured variables that might predict retention, because we are limited as to the number of cells 
that can reasonably be generated to which to assign weights. (A particular advantage to using this 
procedure is that it takes into account any interactions among the predictor variables, such as an 
interaction of gender and race.) Secondly, and more generally, even with a prediction model that 
accounts for nearly all of the variance in retention, there still could be some unmeasured 
characteristics that differentiate the people in each cell who do and do not remain in the study. 
As we stated earlier, one of the most important uses of these data will be to track historical 
changes in the major HIV/AIDS risk and protective behaviors in the general population, a 










PREVALENCE/FREQUENCY OF RISK BEHAVIORS 
AMONG 21- TO 30-YEAR-OLDS 
 
In this section we present and discuss the prevalence and frequency of several HIV/AIDS-related 
risk behaviors measured among 21- to 30-year-olds in the MTF follow-up surveys of 2004 
through 2008 combined*. We begin by presenting data on the combined samples for all 
respondents (total weighted N = 10,176 observations) and for males and females separately 
(weighted Ns = 4,787 and 5,389 observations, respectively). (As noted earlier, the number of 
different individuals is lower.) Results are included for several risk behaviors: injection drug use, 
having sex with same-gender partners, number of partners, and donating blood. In looking at the 
gender of the subject’s sex partner(s) in the prior 12 months, we distinguish six configurations: 
males with females, males with males, males with partners of both genders, females with males, 
females with females, and females with partners of both genders. The case counts turn out to be 
quite small in the two categories that involve sexual contact with partners of the same gender—
either for male respondents or female respondents—so the reader is cautioned to pay particular 
attention to the numbers of observations for these groups. 
 
Injection Drug Use 
While not itself a vector of HIV transmission, the amount of illicit injection drug use determines 
the pool of eligible persons from which the high-risk behavior of needle sharing is drawn. The 
question to respondents reads, “On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, or steroids) in your lifetime? Do not 
include anything you took under a doctor’s orders.” A sequel question asks about such behavior 
in the prior 12-month interval. Trends in the prevalence of these behaviors would be indicative of 
changes in the pool of persons at risk for sharing of needles. 
 
 Table 1 shows that 1.7% of this five-year combined sample reports having ever used any 
drug by injection without medical supervision, and there is a fair-sized gender 
difference—2.5% of males and 0.9% of females indicate such behavior. The percentages 
using on 40 or more occasions is 0.4% overall—0.5% for males and 0.3% for females. So 
a relatively limited segment—about 1 in every 59 respondents—has ever used an illicit 
drug by injection; a smaller proportion—about 1 in every 250 respondents—reports an 
extended pattern of use. Of course, even though these appear to be very low prevalence 
rates, they can still result in significant absolute numbers of users in the population. 
According to the 2000 Census, there are nearly 40 million Americans ages 21 to 30, so 
1% would represent almost 400,000 individuals. 
 
 The proportions who have injected drugs during the past 12 months without medical 
supervision is considerably smaller: 0.5% overall—1 in every 200 respondents—
including 0.8% of males and 0.3% of females. The proportions using 40 or more times in 
the past 12 months are 0.1% overall, 0.2% for males, and 0.1% for females. 
 
*This combining of five years of survey data provides a much needed increase in total numbers of cases, compared with reporting just the most 
recent year or two. As will be seen in the later section on trends, the results are sufficiently stable to warrant this combining across years. 
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The risk of catching or transmitting a number of blood-borne diseases, including HIV, emerges 
when injection drug use is combined with the sharing of needles. Immediately following the 
questions about injecting illicit drugs, discussed above, the following question was asked about 
needle sharing: “Have you ever taken such drugs using a needle that you knew (or suspected) 
had been used by someone else before you used it?” 
 
 The proportion who say they have ever shared needles in this way during their lifetime is 
0.4% overall—0.5% of males and 0.4% of females (Table 1). As noted above, 1.7% of 
the full samples say they have ever injected a drug, so it follows that about one in four of 
the injectors shared a needle at some time. 
 
 The proportion who say that they have shared needles in the prior 12 months is 0.1%, 
with 0.2% of males and 0.1% of females reporting such behavior. This compares to 0.5% 
who say that they have injected a drug in the prior 12 months, so here again only a 
minority of these injectors shared a needle during that interval. 
 
 Males appear more likely than females to have engaged in injecting drugs and sharing 
needles, though the gender differences are not large. 
 
 In sum, needle-sharing behavior appears to have a very low prevalence among high 
school graduates ages 21 to 30. Again, it seems likely that this is an underestimate for the 
entire population in this age range due to the omission of high school dropouts, the 
likelihood that drug-addicted users would be more likely than average to leave the study 
and the possibility that there may be some underreporting of this behavior. Nevertheless, 
it appears that this is a low-prevalence behavior for the age group. 
 
Sex with Multiple Partners 
Having sexual relations with multiple partners is another class of behaviors that increases the risk 
of HIV transmission. The question on this behavior was, “During the last 12 months, how many 
sex partners have you had? (This includes vaginal, oral, or anal sex.)” We believed that, for 
clarity, the nature of the sexual encounters to be included in the answers had to be specified; we 
included these three types of sexual activity because all can involve the transmission of HIV. 
Results are provided in Table 2. 
 
 About one seventh (14%) of 21- to 30-year-old respondents reported not having any sex 
partners during the prior 12 months—15% of males and 13% of females. 
 
 The most common answer by far to this question was having just one partner during the 
year (62% overall), with a lower proportion of males (57%) than females (66%) giving 
this answer. 
 
 That leaves about one quarter (24%) of the sample of young adults ages 21 to 30 
reporting that they have had multiple (two or more) sex partners in the prior 12 months—
28% of males and 22% of females. 
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 While having even one sex partner is not without risk, the risk rises rapidly with an 
increased number of partners. One in ten reported that they had a total of two partners 
during the year (9.3% of males and 10.0% of females); 5.8% reported three partners 
(6.5% of males and 5.2% of females); leaving about one in eleven (8.8%) reporting 
having four or more partners (11.7% of males and 6.4% of females). Very few report 
having more than 20 partners (0.2% of males and 0.1% of females). 
 
 In addition to being more likely to inject drugs and share needles, males are also more 
likely to have had multiple sex partners, and males are particularly more likely to have 
had four or more partners. 
 
Sex with Partners of the Same Gender 
Because males who have sexual contact with other males have been at particular risk of 
contracting and transmitting HIV, we also looked at subgroups by the different gender 
combinations. Only people reporting that they have had sexual contact with one or more partners 
in the prior year are asked the question: “During the last 12 months, have your sex partner or 
partners been . . . .” The answer alternatives are: “exclusively male,” “both male and female,” 
and “exclusively female.” See Table 2 for the results. 
 
 Of the respondents having one or more sex partners in the prior 12 months, 95% of males 
reported that their partners were exclusively female, and almost exactly the same 
proportion (96%) of females indicated that their partners were exclusively male. 
 
 That leaves 5.2% of males indicating some sexual contact with other males during the 
last 12 months—4.3% saying that their partners were males exclusively and 0.9% saying 
that they had both male and female partners. 
 
(Note that because of the low prevalence rates for these behaviors, the weighted numbers 
of cases is limited: a total of 211 observations from male respondents who reported 
having any sexual contact with other males—173 reported having sex exclusively with 
other males, and 38 reported having sex with both genders. [The corresponding weighted 
numbers of different individuals are 127, 99, and 28.] For data on the numbers of sex 
partners each of these groups reported, see Table 2.) 
 
 Among females, 3.8% reported having any female sex partners—2.0% of all female 
observations indicated partners that were exclusively female and 1.8% indicated that their 
partners were of both genders. 
 
(Again, note that the numbers of observations available for study are limited: 177 reports 
of having any sexual contact with other females, 95 reports of having sex with other 
females exclusively, and 83 reports of having sex with both female and male partners. 
The corresponding weighted numbers of different individuals are 120, 61, and 59.) 
 
 Once more, males are at greater risk than females (a) because males are more likely to 
engage in same-gender sexual activity, and (b) because those encounters almost certainly 
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While donating blood carries no risk of contracting an HIV infection, because only new and 
sterile needles are used to draw blood from donors, it does present the possibility of transmitting 
HIV if the donor is infected*. The question of relevance here is to what extent is blood donated 
by young adults who are at higher than average risk of carrying HIV? We begin with the overall 
prevalence of blood donation shown in Table 3. 
 
 The proportion of respondents saying that they have donated blood or blood plasma 
during their lifetime is 45% overall, with similar proportions for males and females 
(Table 3). 
 
 Blood donation in the previous 12 months was reported by 11% overall—12% of males 




























*This risk has been dramatically reduced in recent years by the routine screening of donated blood for HIV. Still, the Red Cross estimates that, if 
someone first became infected with HIV within what they call the “window period,” which they define as 12 to 16 days before donating blood, 
the infection might not be detected in the screening tests (http://www.wcredcross.org/bloodmobile/qa_aids.html). Further, the data presented here 
suggest that at least one high-risk group that is not supposed to donate blood has been doing so.  
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INTERSECTION OF RISK BEHAVIORS 
 
One goal of MTF is to determine to what extent these various risk behaviors overlap one another, 
and to determine what proportion of the population is at heightened risk of HIV transmission as a 
result. We next report several pairwise combinations of risk factors. 
 
 
Needle Sharing among Those with Same-Gender Partners 
Needle sharing and sex with same-gender partners (particularly for males) are known to be 
among the most important vectors for the spread of HIV. 
 
 Table 4 provides information on injection drug use and needle sharing by the six 
categories of gender of partners. The very small numbers of cases in the important group 
of those having sexual relations with both genders again make any results tentative and 
suggestive. However, it does appear that both injecting and needle sharing tend to be 
highest among those who engage in sex with both genders. This holds true for both male 
and female respondents. 
 
 Males who report having exclusively male partners have about the same lifetime 
prevalence of injection as males having exclusively female partners, but they have a 
slightly higher prevalence of injecting a drug the prior 12 months (1.2% vs. 0.7%, 
respectively). They also have a higher lifetime and 12-month prevalence of needle 
sharing. So, there is some compounding of these two types of risk among males. 
 
 Among females, the lifetime prevalence of injecting drugs is higher among those having 
exclusively female partners (3.2% vs. 0.8%) and, more importantly, the lifetime 
prevalence of needle sharing is also higher (3.3% vs. 0.3%). Interestingly, there is 
virtually no difference between these two groups in the prevalence of injecting or needle 
sharing in the prior 12 months, so the heightened risk from needle sharing for women 
who have exclusively female partners appears to have occurred when they were younger. 
 
Needle Sharing by Number of Partners 
 The likelihood of injecting drugs either in one’s lifetime or in the prior 12 months rises 
considerably with the number of partners reported in the prior 12 months, as does the 
likelihood of sharing a needle (Table 5). For example, those who report two partners or 
less report a prevalence of needle sharing in the prior 12 months of 0.1% or less, whereas 
those reporting five or more partners have a prevalence of 1.4%. The association holds 
for both males and females. This means that needle sharers, who are at particular risk of 





HIV/AIDS: Risk & Protective Behaviors among American Young Adults 
 
 
Number of Partners among Those with Same-Gender Partners 
 We examined the number of partners reported as a function of the genders of those 
partners (Table 6). For sexually active males who had sex exclusively with other males 
during the year (N = 173 observations), about half (54%) reported that they had only one 
sex partner. (This compares with a single partner rate of 69% among the males who 
reported that they had sexual contact exclusively with females.) About a fifth (18%) of 
males with exclusively male partners reported sexual contact with five or more partners, 
compared to 8% for males with exclusively female partners. Thus, although their 
proportion of the total population is small, and these particular findings are thus based on 
a small subsample, it appears that appreciable numbers of young adult males are 
potentially placing themselves at considerable risk by having multiple sex partners, and 
this is especially true for males who have had sex with other males during the year. 
 
 Among sexually active females who had sex exclusively with other females during the 
year (N = 95), 80% reported having only one partner, indicating a high level of 
monogamy in this group. (This rate is very close to the 77% who reported being 
monogamous among females who had male partners exclusively.) Again, these estimates 
are only suggestive given the very limited sample size involved. 
 
 Individuals who have sexual relations with both genders carry the risk of spreading HIV 
across genders, making their behavior of particular importance. The numbers of cases 
collected to date are very small; weighted Ns = 83 observations for females and 38 for 
males reporting relations with partners of both genders in the prior 12 months. The small 
numbers clearly render the results only tentative and suggestive. Nevertheless, based on 
the 121 cases who report partners of both genders, the proportion reporting five or more 
partners appears to be quite high. (See Table 6.) 
 
Donating Blood by Needle Sharing 
 There is an inadequate sample size to examine the intersection between needle sharing 
and blood donation because the numbers of respondents indicating shared needle use, 
either in their lifetime or in the past 12 months, were too small (Ns = 47 and 14, 
respectively). In the future, by concatenating across years, we may be able to examine 
this intersection. 
 
Donating Blood by Those with Same-Gender Partners 
 About equal proportions of males who reported any male sex partner(s) during the 
previous 12 months (46% based on 160 weighted observations) and males who reported 
only female sex partners (47%) said they had ever donated blood (Table 7). Slightly 
fewer of the men reporting any male sex partners said they donated blood in the prior 12 
months (10%, versus 12% among males reporting only female partners), a statistically 
nonsignificant difference. Whether or not the difference is real, it is clear that by no 
means all individuals in this elevated risk group abstain from donating blood, as the 
Food and Drug Administration requires. Rather, their rate of blood donation appears very 
similar to the rate for all males. 
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 Females who have exclusively male partners have higher reported prevalence of donating 
blood than do females whose partners include other females. 
 
Donating Blood by Number of Partners 
 The results in Table 8 show little systematic association between the number of partners 
reported in the prior 12 months and the prevalence of donating blood in the prior 12 
months. Lifetime prevalence of donating blood is lower in the group reporting no sex 









PREVALENCE OF PROTECTIVE BEHAVIORS 
 
People can take various precautions to diminish their likelihood of contracting HIV and/or 
transmitting it to others. One, of course, is simply to avoid the high-risk behaviors already 
discussed, and to avoid donating blood if one is a male with a history of having male sex 
partners. Another is to use protection against viral transmission in the form of condom use during 
intercourse. A third approach—getting tested for HIV—increases the likelihood that an infected 
individual will receive appropriate treatment and also, if the diagnosis is positive, refrain from 
behaviors that put others at risk of contracting the virus. Blood donation has already been 
discussed; answers to the questions about condom use and HIV testing are discussed next. 
 
Condom Use 
Respondents who indicated that they had one or more sexual partners during the prior 12 months 
were asked, “When you had sexual intercourse during the last 12 months, how often were 
condoms used? (This includes vaginal and anal sex, but not oral sex.)” The answer alternatives 
were: never, seldom, sometimes, most times, and always. Both genders responded to this 
question. (Respondents who reported no sex partners in the prior 12 months are excluded from 
the data presented here.) 
 
 The majority (55%) of sexually active young adult respondents said that they “seldom” or 
“never” used condoms during the year—with 50% of males and 59% of females giving 
one of these answers (see Table 9). Indeed, a large proportion (41%) indicated that they 
did not use condoms at all during the prior 12 months—36% of the sexually active males 
and 46% of the sexually active females. Higher rates of monogamy among females may 
help to explain their lower rate of condom use; however, their partners may or may not be 
monogamous, and if not, the risk to the woman increases, quite possibly without her 
awareness. 
 
 Only about one third (33%) of sexually active young adults said that they used a condom 
“most times” or “always”—37% of males and 29% of females. 
 
Getting Tested for HIV 
Respondents were asked if they had ever been tested for HIV/AIDS; they were instructed not to 
include any testing that they may have undergone when they were donating blood or blood 
plasma. The results may be found in Table 10. 
 
 Less than half (44%) of all young adults ages 21 to 30 indicate that they have ever been 
tested for HIV outside of blood donation screening—37% of males and 50% of females. 
 
 About one fifth (21%) say they have been tested in the prior 12 months—17% of males 
and 24% of females. 
 
 Not all of those who took HIV tests, however, actually received their results. Asked if 
they received the results of their most recent HIV test, 7.5% of those who had ever been 
tested said that they had not—8.9% of males and 6.6% of females tested. Thus, females 
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are somewhat more likely than males to engage in this protective behavior—including 
obtaining the results of the tests—even though they are at somewhat less risk than males 









INTERSECTION OF PROTECTIVE BEHAVIORS 
 
To the extent that people who use one type of protection against HIV transmission are more 
likely to use another, we may have an indication of individual differences in protection against 
HIV/AIDS in general. We look here at the degree of association between getting tested and using 
condoms. 
 
Frequency of Condom Use by Getting Tested for HIV 
 Are people who take the precaution of using condoms also the ones who are getting 
tested for HIV? The answer appears to be no (Table 11). Of those who say they “always” 
use condoms, slightly fewer (18%) indicate getting tested for HIV in the prior 12 months, 
compared to 26–28% of those who say they seldom, sometimes, or most times use 
condoms. Perhaps those who always use condoms consider themselves to be at less risk 
of having contracted HIV, and they are, of course. Those sexually active respondents who 
say they never use condoms are also slightly less likely to have been tested in the prior 12 
months (21%) than the middle groups. Overall, there is rather little association between 











INTERSECTION OF RISK AND PROTECTIVE BEHAVIORS 
 
Frequency of Condom Use by Number of Partners 
 Only about one third (33%) of sexually active young adults said that they used a condom 
“most times” or “always”—37% of males and 29% of females (Table 9). This statistic 
rises considerably with the number of partners (Table 12). 
 
 As might be expected, many of those not using condoms are respondents who had only 
one partner during the year. Among those reporting only one partner (the majority of all 
respondents), 52% said they did not use condoms at all in the last 12 months. That 
statistic fell by more than half among those reporting two partners (to 20%), by about half 
again among those reporting three or four partners (to 13%), and still further among those 
reporting five or more partners (10%). 
 
 In sum, using condoms to prevent exposure to—and transmission of—HIV (and many 
other sexually transmitted diseases) is considerably more prevalent among those who are 
at heightened risk due to the number of sexual partners that they have. That is the 
encouraging part of this finding, but even 56% using “most times” or “always” is far 
short of 100% using “always,” which is the ideal condition from a public health point of 
view. 
 
Frequency of Condom Use by Gender of Partners 
 There have been considerable efforts made in past years to encourage the use of condoms 
by men who have sexual relations with men, with the obvious intent being to stem the 
spread of HIV/AIDS in that population. While the numbers of such cases available here 
for analysis are quite limited (weighted N = 210), results suggest that the use of condoms 
in this population is probably higher than in the population of men reporting sex 
exclusively with women in the prior year—35% reporting never (versus 36% in the latter 
group), but 42% reporting “most times” or “always” (versus 37% in the latter group) . 
The rate of condom use among men having sexual relations only with women is likely 
suppressed somewhat by the proportion seeking to conceive a child and also by those 
who feel that they are in a monogamous relationship and therefore less likely to be 
exposed to HIV (Table 13). 
 
Getting Tested for HIV by Gender of Partners 
 Because males having sexual contact with male partners are at heightened risk for 
contracting and/or transmitting HIV, we looked to see if HIV testing was more prevalent 
among them (Table 14). While the number of cases is small (again, 210 weighted cases), 
the results are suggestive of increased vigilance in this population. Nearly two thirds 
(64%) of males having exclusively male partners in the prior year indicated being tested 
for HIV at some time, and nearly four in every ten (38%) said that they had been tested in 
just the past year. These rates compare to 40% and 18%, respectively, among males who 
have had female partners exclusively during the past year. Hardly any (2.4%) of the 
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males reporting relations exclusively with other men in the past year said that they failed 
to get the results of their most recent test, versus 8.3% of those who had only female 
partners. 
 
Getting Tested for HIV by Number of Partners 
 The prevalence of getting tested for HIV rises with the number of partners reported in the 
prior 12 months (Table 15). While only 7% of those reporting no partners in the prior 12 
months say that they have been tested in the prior 12 months, the rate rises to 19% of 
those reporting one partner, 31% for those reporting two partners, and up to 35% for 
those reporting five or more partners. 
 
 The proportion getting the results of their tests is high in all groups, but it does rise with 
the number of partners reported. 
 
 It thus appears that those at increased risk because of the number of partners with whom 
they have had sexual encounters are more likely to exhibit the protective behaviors of 
getting tested and securing the results of the test. However, about two thirds of those 
reporting multiple partners did not have an HIV test in the prior year. 
 
This has been a reporting of the prevalence of risk and protective behaviors associated with the 
spread of HIV among young adults in the general population, and of the intersection of these 
various risk and protective behaviors. We believe there is also considerable value in tracking 
change in the prevalence of these risk and protective behaviors among young adults. While the 
numbers are still small, especially for estimating the intersection of some of the most rare 
behaviors like needle sharing and having same-gender sex partners, ongoing data collections 
should allow us to monitor these behaviors and provide more in-depth consideration of important 
subgroups and correlates. Adding these questions to additional questionnaire forms has 











TRENDS IN THE PREVALENCE AND 
FREQUENCY OF RISK BEHAVIORS 
 
The 2008 MTF data collection is the fifth to include this set of questions on HIV risk and 
protective behaviors. We have chosen to present the trend data in the form of two-year moving 
averages in order to smooth the trend estimates and reduce fluctuations due primarily to 
sampling error. This is done by taking an arithmetic average of the results for the year labeled at 
the top of each column and the results from the prior year. The sample size increased in 2007 due 
to the inclusion of this set of questions in an additional questionnaire form; but the 2006 and 
2007 data are weighted equally in calculating the two-year moving average for 2007. 
 
As can be seen in Tables 16 through 18 and Figures 1 and 2, there has been very little movement 
over the four years for which estimates have been calculated in any of the risk behaviors under 
study. Indeed, there is a very high level of replication of the results, which serves as evidence of 
the reliability of these estimates. 
 
Table 16 and Figure 1 show no systematic change over the interval 2005–2008 among 21- to 30-
year-olds in the prevalence of frequency of lifetime or past-year drug injection rates or needle 
sharing. 
 
Table 17 and Figure 2 show no systematic change over the same interval (2005–2008) in the 
number of sex partners that respondents report having in the prior year, and the differences by 
year in the prevalence of having more than one partner are far from statistically significant. 
 
The proportions of respondents reporting sex with partners of the same gender during the prior 
year also showed no systematic change, nor did the rate of blood donation (Tables 17 and 18, 








TRENDS IN THE PREVALENCE AND 
FREQUENCY OF PROTECTIVE BEHAVIORS 
 
Like the risk behaviors, the behaviors that can help to protect against the spread of HIV have 
shown very little change in the 2005–2008 interval. While there may be some very slight rise in 
the reported prevalence of condom use (Table 18 and Figure 3), it is not statistically significant. 
There has been no systematic change in the lifetime or annual prevalence of respondents getting 
tested for HIV/AIDS, nor in the rate that those tested have secured the test results (Table 17 and 
Figure 3). 
 
It thus appears that movement in both the risk and protective behaviors related to the spread of 
HIV in the young adult population is going to be gradual. The high degree of replication of these 
findings across sequential national surveys gives considerable evidence of the reliability of these 











Risk behaviors for the spread of HIV/AIDS are all too prevalent among today’s young adults. 
The number of young adults who engage in sex with multiple partners and the number of men 
who engage in the high-risk behavior of having unprotected sex with other men are perhaps the 
most important. About one quarter (24%) of these 21- to 30-year-old respondents indicated 
having more than one sex partner in the prior 12 months, 9% said they had more than three 
partners (12% of males and 7% of females), and 5% said they had five or more partners. Among 
sexually active male respondents, about one in twenty (5.2%) indicated having had sex with a 
male partner in the prior 12 months, with the majority (4.3%) reporting having had only male 
partners. 
Men reporting sex with men are considerably more likely to have multiple partners than men 
reporting sex with only female partners, thus compounding their risk. While this very high-risk 
group uses condoms slightly more frequently than men who have sex exclusively with women, 
the differences are small and not statistically significant—42% say they use condoms “most 
times” or “always” versus 37% in the latter group. Condom use rises considerably with having 
multiple sex partners. The higher the number of partners reported, the higher the rate of condom 
use; and this holds true for both genders.  
Some 38% of men who report having sex exclusively with men in the prior 12 months indicate 
having been tested for HIV/AIDS in the same interval. This compares with only 18% of men 
who report having sex exclusively with women. (The former group is also more likely to obtain 
the results of the test.) Among all respondents the proportion getting tested for HIV/AIDS rises 
with the  number of sex partners reported, though even among those with five or more partners 
during the year, only 35% indicate being tested in that interval. These data suggest that a number 
of people recognize that their sexual practices put them at greater risk and try to do something 
about it, even if it is simply to determine whether they are already infected. Interestingly, 
condom use and HIV testing—two risk reduction behaviors—do not seem to correlate with each 
other, as might have been expected. 
Men who have had sex with men are not supposed to donate blood, lest they potentially put 
others at risk; but the evidence here is that relatively few are deterred from doing so. Some 43% 
of males who report having any sex with men in the prior year indicate having given blood at 
some time in their lifetime (vs. 47% for those not reporting sex with men), and 9% indicate 
donating in just the past year (vs. 12%). Also, respondents reporting high numbers of sex 
partners donate blood in similar proportions as those reporting few partners. Thus it seems that 
blood banks have not been entirely successful at screening out high-risk donors, despite their 
attempts to do so. 
“Only” about 0.4% of 21- to 30-year-old respondents surveyed in 2004–2008 (combined) 
admitted to ever sharing needles in their lifetime—0.1% in the prior 12 months. Although these 
respondents represent a small proportion of the population, they are a particularly high-risk 
group, and we believe it likely that our estimates of the size of this group are low. 
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Findings reported here are based on the five years of data collection combined; and, as we have 
stated at various points in this monograph, even then the numbers of cases often are not 
sufficient to reach statistical significance—particularly when some of the most rare behaviors are 
involved. But the data are highly suggestive and tend to replicate, giving us increased confidence 
in their validity. 
The extent to which these HIV/AIDS risk and protective behaviors are changing over time is of 
great importance to the country, and the evidence here from the most recent five-year interval 
suggests that little change is taking place. In other words, there is little evidence of progress 
being made during this period. As we have argued in the context of drug abuse, there is always a 
danger of generational forgetting—that through generational replacement, younger cohorts may 
not acquire the knowledge about risks that earlier cohorts possessed, which led them to avoid 
risky behaviors. It seems likely that there has been a considerable shift over the past two decades 
in the perceived dangers of HIV/AIDS, leaving recent cohorts of young adults more vulnerable 
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Total Male Female
Lifetime Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, or 
steroids) in your lifetime? Do not include anything you took 
under a doctor’s orders.
    0 Occasions 98.3 97.5 99.1
    1–2  0.5  0.7  0.4
    3–5  0.2  0.4  0.1
    6–9  0.2  0.3 *
    10–19  0.2  0.4  0.1
    20–39  0.2  0.3 *
    40+ Occasions  0.4  0.5  0.3
Weighted N = 10,174 4,786 5,388
Annual Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, or 
steroids) during the last 12 months? Do not include anything 
you took under a doctor’s orders.
    0 Occasions 99.5 99.2 99.7
    1–2  0.1  0.2  0.1
    3–5 * * *
    6–9  0.1  0.2 *
    10–19  0.1  0.1 *
    20–39  0.1  0.1 *
    40+ Occasions  0.1  0.2  0.1
Weighted N = 10,176 4,787 5,389
Lifetime and Annual Needle Sharing
Have you ever taken such drugs using a needle that you knew 
(or suspected) had been used by someone else before you 
used it?
    Yes, in the last 12 months  0.1  0.2  0.1
    Yes, but not in the last 12 months  0.3  0.3  0.3
    No, never 99.5 99.5 99.6
Weighted N = 10,076 4,740 5,337
Source.  The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.




Injection Drug Use and Needle Sharing,
Total and by Gender
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
Lifetime and Last 12 Months:
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Total Male Female
Number of Partners in Last 12 Months
During the LAST 12 MONTHS, how many sex 
partners have you had? (This includes vaginal, oral, 
or anal sex.)
    None 13.9 15.3 12.7
    One 61.7 57.1 65.7
    Two  9.7  9.3 10.0
    Three  5.8  6.5  5.2
    Four  3.7  4.3  3.3
    5–10  4.0  5.5  2.7
    11–20  0.8  1.3  0.3
    21–100  0.2  0.4  0.1
    More than 100  0.1  0.2  0.1
Weighted N = 10,142 4,773 5,370
Gender of Partners in Last 12 Monthsb
During the LAST 12 MONTHS, have your sex 
partner or partners been …
    Exclusively male? 53.6  4.3 96.2
    Both male and female?  1.4  0.9  1.8
    Exclusively female? 45.0 94.8  2.0
Weighted N = 8,721 4,042 4,680
Source.  The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added 
to a third questionnaire form.
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting  
no partners are omitted.
(Entries are percentages.)
TABLE 2
Number of Partners and Gender of Partners:
Total and by Gender
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
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Total Male Female
Blood Donation: Lifetime and Last 12 Months
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 10.5 11.5  9.5
    Yes, but not in the last 12 months 34.5 34.2 34.7
    No, never 55.1 54.3 55.7
Weighted N = 10,227 4,815 5,412
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added 
to a third questionnaire form.
(Entries are percentages.)
TABLE 3
Blood Donation, Lifetime and Last 12 Months:
Total and by Gender
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
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Female Male Male and Male Female Male and
Only Only Female Only Only Female
Lifetime Frequency of Injecting
On how many occasions (if any) have you taken any 
drugs by injection with a needle (like heroin, cocaine, 
amphetamines, or steroids) in your lifetime? Do not 
include anything you took under a doctor’s orders.
    0 Occasions 97.3 97.5 85.4 99.2 96.8 92.4
    1–2 0.7 1.1 1.5 0.4 0.3 2.8
    3–5 0.4 0.2 * 0.1 2.6 0.3
    6–9 0.2 0.3 6.4 * * 1.0
    10–19 0.5 * * 0.1 * 0.4
    20–39 0.3 * 3.1 0.1 * *
    40+ Occasions 0.4 0.8 3.6 0.3 0.3 2.9
Weighted N = 3,817 173 37 4,493 94 83
Annual Frequency of Injecting
On how many occasions (if any) have you taken any 
drugs by injection with a needle (like heroin, cocaine, 
amphetamines, or steroids) during the last 12 months? 
Do not include anything you took under a doctor’s 
orders.
    0 Occasions  99.3  98.8  86.4  99.8  100.0  96.0
    1–2  0.2  0.3  1.5 * *  1.9
    3–5 * * * * * *
    6–9  0.2 *  6.4 * * *
    10–19  0.1 *  3.1 * *  0.4
    20–39  0.1 *  2.6 * * *
    40+ Occasions  0.1  0.8 *  0.1 *  1.8
Weighted N = 3,818 173 37 4,494 94 83
Lifetime and Annual Needle Sharing
Have you ever taken such drugs using a needle that 
you knew (or suspected) had been used by someone 
else before you used it?
    Yes, in the last 12 months 0.1 0.8 2.6 0.1 * 2.2
    Yes, but not in the last 12 months 0.2 0.6 2.8 0.3 3.3 1.3
    No, never 99.6 98.6 94.6 99.7 96.7 96.5
Weighted N = 3,783 173 37 4,452 95 81
Source.  The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
by Gender of Partners in Last 12 Months 
Injection Drug Use and Needle Sharing,  
TABLE 4
Gender of Partner(s)Gender of Partner(s)
MALE RESPONDENTS FEMALE RESPONDENTS
(Entries are percentages.)
Lifetime and Last 12 Months
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Three  Five   
None One Two or Four or More
Lifetime Frequency of Injecting 
On how many occasions (if any) have you taken any drugs by injection 
with a needle (like heroin, cocaine, amphetamines, or steroids) in your 
lifetime? Do not include anything you took under a doctor’s orders.
    Total
    0 Occasions 99.2 98.6 98.2 97.2 94.5
    1+ Occasions 0.8 1.4 1.8 2.8 5.5
Weighted N = 1,407 6,239 981 967 520
    Males
    0 Occasions 98.8 97.8 97.5 96.2 93.5
    1+ Occasions 1.2 2.2 2.5 3.8 6.5
Weighted N = 727 2,718 446 511 353
    Females
    0 Occasions 99.7 99.2 98.8 98.3 96.7
    1+ Occasions 0.3 0.8 1.2 1.7 3.3
Weighted N = 679 3,521 535 456 167
Annual Frequency of Injecting 
On how many occasions (if any) have you taken any drugs by injection 
with a needle (like heroin, cocaine, amphetamines, or steroids) during 
the last 12 months? Do not include anything you took under a doctor’s 
orders.
    Total
    0 Occasions 99.6 99.8 99.6 99.0 96.6
    1+ Occasions 0.4 0.2 0.4 1.0 3.4
Weighted N = 1,408 6,241 981 966 520
    Males
    0 Occasions 99.6 99.6 99.6 98.4 96.2
    1+ Occasions 0.4 0.4 0.4 1.6 3.8
Weighted N = 728 2,719 446 510 353
    Females
    0 Occasions 99.7 99.9 99.7 99.6 97.6
    1+ Occasions 0.3 0.1 0.3 0.4 2.4
Weighted N = 679 3,522 535 456 167
Needle Sharing: Lifetime and Last 12 Months
Have you ever taken such drugs using a needle that you knew (or 
suspected) had been used by someone else before you used it?
    Total
    Yes, in the last 12 months 0.1 * 0.1 0.3 1.4
    Yes, but not in the last 12 months 0.4 0.3 0.5 0.4 0.2
    No, never 99.5 99.7 99.4 99.4 98.4
Weighted N = 1386 6187 969 958 516
    Males
    Yes, in the last 12 months 0.1 0.1 * 0.3 1.3
    Yes, but not in the last 12 months 0.8 0.2 0.5 0.4 0.1
    No, never 99.1 99.7 99.5 99.3 98.6
Weighted N = 716 2,698 438 507 350
    Females
    Yes, in the last 12 months * * 0.2 0.2 1.6
    Yes, but not in the last 12 months * 0.3 0.5 0.3 0.5
    No, never 100.0 99.7 99.3 99.5 98.0
Weighted N = 671 3,490 530 452 166
Source.  The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
Number of Partners in Last 12 Months
TABLE 5
Injection Drug Use and Needle Sharing 
by Number of Partners, Lifetime and Last 12 Months:
Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
Total and by Gender among
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Female Male Male and Male Female Male and
Only Only Female Only Only Female
Number of Partners in Last 12 Months
During the LAST 12 MONTHS, how many sex 
partners have you had? (This includes vaginal, oral, 
or anal sex.)
    None — — — — — —
    One 68.6 53.7 10.6 76.5 80.0 7.1
    Two 11.0 9.9 21.9 11.2 10.1 24.0
    Three 7.5 10.5 7.9 5.7 4.0 24.0
    Four 4.9 8.2 15.7 3.5 4.0 16.5
    5–10 6.2 9.3 32.4 2.7 1.9 22.2
    11–20 1.3 4.8 9.0 0.3 * 3.8
    21 or more partners 0.6 3.7 2.5 0.1 * 2.4
Weighted N = 3,813 173 38 4,494 95 83
Source.  The Monitoring the Future study, the University of Michigan.
“—” indicates “not applicable.”
“*” indicates a prevalence rate of less than 0.05%.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
Gender of Partner(s) Gender of Partner(s)
TABLE 6
Number of Partners by Gender of Respondents and Partners in Last 12 Months 
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
MALE RESPONDENTS FEMALE RESPONDENTS
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Female Male Male and Male Female Male and
Only Only Female Only Only Female
Blood Donation: Lifetime and Last 12 Months
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 11.6 8.8 11.2 9.7 5.4 5.6
    Yes, but not in the last 12 months 35.5 31.1 48.2 35.5 39.4 44.2
    No, never 52.9 60.1 40.6 54.8 55.2 50.2
Weighted N = 3,820 173 38 4,488 95 83
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
TABLE 7
MALE RESPONDENTS FEMALE RESPONDENTS
Gender of Partner(s) Gender of Partner(s)
(Entries are percentages.)
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
Blood Donation by Gender of Respondents and Partners, 
Lifetime and Last 12 Months
38
Three   Five   
None One Two or Four or More
Blood Donation: Lifetime and Last 12 Months
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 11.0 10.2 12.0 10.4 10.7
    Yes, but not in the last 12 months 28.2 36.3 29.8 37.2 35.7
    No, never 60.8 53.6 58.2 52.4 53.6
Weighted N = 1,404 6,240 978 968 520
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
Number of Partners in Last 12 Months
TABLE 8
Blood Donation, Lifetime and Last 12 Months
by Number of Partners in Last 12 Months




Frequency of Condom Use in Last 12 Monthsb
When you had sexual intercourse during the LAST 
12 MONTHS, how often were condoms used? 
(This includes vaginal and anal sex, but not oral 
sex.)
    Never 41.1 36.1 45.5
    Seldom 13.5 13.7 13.3
    Sometimes 12.8 13.0 12.7
    Most times 15.2 16.8 13.8
    Always 17.3 20.4 14.7
Weighted N = 8,653 4,019 4,634
Source.  The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added 
to a third questionnaire form.
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting  
no partners are omitted.
TABLE 9
Frequency of Condom Use in Last 12 Months: 
Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
Total and by Gender among
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Total Male Female
Test for HIV: Lifetime and Last 12 Months
Have you ever been tested for HIV/AIDS? (Do not 
include tests that you may have had when donating 
blood or blood plasma.)
    Yes, in the last 12 months 20.5 16.5 24.0
    Yes, but not in the last 12 months 23.4 20.9 25.6
    No, never 56.1 62.6 50.4
Weighted N = 10,227 4,815 5,412
Received HIV Test Resultsb
Did you receive the results of your most recent 
HIV/AIDS test? (We don’t want to know your test 
results.)
    Yes 92.5 91.1 93.4
    No  7.5  8.9  6.6
Weighted N = 4,444 1,789 2,654
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added 
to a third questionnaire form.
bThose respondents who report never having been tested for HIV are excluded from these percentages. 
TABLE 10
Test for HIV/Receive HIV Test Results:
Total and by Gender
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
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Never Seldom Sometimes Most Times Always
Test for HIV: Lifetime and Last 12 Months
Have you ever been tested for HIV/AIDS? (Do not 
include tests that you may have had when donating 
blood or blood plasma.)
    Yes, in the last 12 months 21.1 26.4 28.4 26.4 17.9
    Yes, but not in the last 12 months 30.1 24.4 22.8 23.6 18.5
    No, never 48.8 49.3 48.8 50.0 63.6
Weighted N = 3,555 1,165 1,108 1,312 1,494
Received HIV Test Resultsc
Did you receive the results of your most recent HIV/AIDS 
test? (We don’t want to know your test results.)
    Yes 92.8 91.8 93.5 94.2 92.9
    No 7.2 8.2 6.5 5.8 7.1
Weighted N = 1,796 587 563 652 541
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting no partners 
are omitted.  
cThose respondents who report never having been tested for HIV are excluded from these percentages. 
Condom Use in Last 12 Monthsb
TABLE 11
Test for HIV/Receive HIV Test Results
by Frequency of Condom Use
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
42
    Three   Five
None One Two or Four or More
Frequency of Condom Use in Last 12 Monthsb 
When you had sexual intercourse during the LAST 12 
MONTHS, how often were condoms used? (This includes 
vaginal and anal sex, but not oral sex.)
    Total
    Never — 51.6 19.9 12.7 10.1
    Seldom — 12.6 16.5 16.3 14.0
    Sometimes — 10.5 18.1 18.8 19.6
    Most times — 9.3 22.9 32.7 38.6
    Always — 16.0 22.7 19.6 17.7
Weighted N = — 6,173 971 963 521
    Males
    Never — 47.2 18.7 11.7 9.2
    Seldom — 13.3 14.5 16.4 11.8
    Sometimes — 10.8 14.9 18.0 19.6
    Most times — 10.1 24.2 30.9 38.2
    Always — 18.5 27.7 22.9 21.2
Weighted N = — 2,694 444 511 354
    Females
    Never — 55.0 21.0 13.7 12.0
    Seldom — 12.0 18.1 16.1 18.6
    Sometimes — 10.2 20.8 19.6 19.6
    Most times — 8.7 21.7 34.7 39.6
    Always — 14.2 18.4 15.9 10.2
Weighted N = — 3,479 527 452 167
Source.  The Monitoring the Future study, the University of Michigan.
“—” indicates “not applicable.”
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
are omitted.  
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting no partners 
TABLE 12
Frequency of Condom Use by Number of Partners in Last 12 Months:
Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
Number of Partners in Last 12 Months
Total and by Gender among
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Female Male Male and Male Female Male and
Only Only Female Only Only Female
Frequency of Condom Use in Last 12 Monthsb
When you had sexual intercourse during the LAST 12 
MONTHS, how often were condoms used? (This 
includes vaginal and anal sex, but not oral sex.)
    Never 36.2 39.4 17.1 45.2 80.3 27.6
    Seldom 13.8 9.4 15.5 13.4 6.8 11.0
    Sometimes 13.0 11.5 16.5 12.8 4.4 16.6
    Most times 16.5 17.2 41.9 13.8 3.9 24.8
    Always 20.4 22.5 9.0 14.8 4.6 20.0
Weighted N = 3,798 172 38 4,456 87 82
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting no partners are 
omitted.
Gender of Partner(s) Gender of Partner(s)
TABLE 13
Frequency of Condom Use by Gender of 
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
MALE RESPONDENTS FEMALE RESPONDENTS
Respondents and Partners in Last 12 Months
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Female Male Male and Male Female Male and
Only Only Female Only Only Female
Test for HIV: Lifetime and Last 12 Months
Have you ever been tested for HIV/AIDS? (Do not 
include tests that you may have had when donating 
blood or blood plasma.)
    Yes, in the last 12 months 17.5 37.6 27.9 26.5 18.9 37.6
    Yes, but not in the last 12 months 22.4 26.8 18.5 27.5 29.5 32.0
    No, never 60.1 35.6 53.6 46.0 51.7 30.4
Weighted N = 3,821 172 38 4,493 95 83
Received HIV Test Resultsb
Did you receive the results of your most recent 
HIV/AIDS test? (We don’t want to know your test 
results.)
    Yes 91.7 97.6 65.6 93.7 87.1 93.6
    No 8.3 2.4 34.4 6.3 12.9 6.4
Weighted N = 1,519 110 16 2,399 46 56
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
bThose respondents who report never having been tested for HIV are excluded from these percentages. 
Gender of Partner(s) Gender of Partner(s)
TABLE 14
Test for HIV/Received HIV Test Results
by Gender of Respondents and Partners 
among Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
MALE RESPONDENTS FEMALE RESPONDENTS
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Three   Five   
None One Two or Four or More
Test for HIV: Lifetime and Last 12 Months
Have you ever been tested for HIV/AIDS? (Do not 
include tests that you may have had when donating 
blood or blood plasma.)
    Yes, in the last 12 months 6.5 19.2 30.7 31.8 34.9
    Yes, but not in the last 12 months 11.9 26.9 21.6 21.3 19.5
    No, never 81.7 53.8 47.7 46.9 45.6
Weighted N = 1,397 6,240 977 970 522
Received HIV Test Resultsb
Did you receive the results of your most recent HIV/AIDS 
test? (We don’t want to know your test results.)
    Yes 86.3 93.0 91.8 91.5 97.0
    No 13.7 7.0 8.2 8.5 3.0
Weighted N = 249 2,856 506 513 281
Source.  The Monitoring the Future study, the University of Michigan.
aIn 2004–2006, the HIV questions were included in two questionnaire forms. In 2007, these questions were added to a third 
questionnaire form.
bThose respondents who report never having been tested for HIV are excluded from these percentages. 
Number of Partners in Last 12 Months
TABLE 15
Test for HIV/Received HIV Test Results, 
Lifetime and Last 12 Months by Number of Partners among
Respondents of Modal Ages 21–30 in 2004–2008a Combined
(Entries are percentages.)
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2004 2005 2006 2007 2008 2004 2005 2006 2007 2008 2004 2005 2006 2007 2008
Lifetime Frequency of Injecting
On how many occasions (if any) have 
you taken any drugs by injection with a 
needle (like heroin, cocaine, 
amphetamines, or steroids) in your 
lifetime? Do not include anything you 
took under a doctor ’s orders.
    0 Occasions — 98.5 98.5 98.3 98.2 — 97.9 97.7 97.4 97.3 — 99.1 99.2 99.0 99.1
    1–2 —  0.5  0.5  0.6  0.5 —  0.6  0.6  0.7  0.7 —  0.3  0.5  0.5  0.3
    3–5 —  0.2  0.2  0.3  0.3 —  0.2  0.3  0.5  0.5 —  0.2  0.1  0.1  0.1
    6–9 —  0.1  0.2  0.2  0.2 —  0.1  0.3  0.4  0.3 — * * * *
    10–19 —  0.3  0.2  0.2  0.2 —  0.5  0.4  0.4  0.4 — * *  0.1  0.1
    20–39 —  0.1  0.1  0.1  0.2 —  0.2  0.2  0.3  0.4 — * * *  0.1
    40+ Occasions —  0.4  0.3  0.3  0.4 —  0.5  0.5  0.4  0.4 —  0.3  0.2  0.2  0.4
Weighted N = — 3,643 3,441 4,076 4,856 — 1,727 1,615 1,904 2,282 — 1,916 1,826 2,172 2,574
Annual Frequency of Injecting
On how many occasions (if any) have 
you taken any drugs by injection with a 
needle (like heroin, cocaine, 
amphetamines, or steroids) during the 
last 12 months? Do not include anything 
you took under a doctor ’s orders.
    0 Occasions — 99.5 99.6 99.6 99.5 — 99.2 99.3 99.2 99.3 — 99.7 99.9 99.8 99.7
    1–2 —  0.1  0.1  0.1  0.1 —  0.2  0.2  0.2  0.1 —  0.1 *  0.1  0.1
    3–5 — *  0.1 * * — *  0.1  0.1 * — * * * *
    6–9 — *  0.1  0.1  0.2 — *  0.1  0.2  0.3 — * * * *
    10–19 —  0.1  0.1  0.1  0.1 —  0.2  0.2  0.1  0.1 — * * * *
    20–39 — * * *  0.1 —  0.1 * *  0.1 — * * *  0.1
    40+ Occasions —  0.2  0.1  0.1  0.1 —  0.2  0.1  0.1  0.1 —  0.2  0.1 *  0.1
Weighted N = — 3,644 3,441 4,077 4,857 — 1,727 1,615 1,905 2,282 — 1,917 1,826 2,172 2,575
Needle Sharing: Lifetime and Last 12 Months
Have you ever taken such drugs using a 
needle that you knew (or suspected) had 
been used by someone else before you 
used it?
    Yes, in the last 12 months —  0.1  0.1  0.1  0.1 —  0.1  0.2  0.2  0.1 —  0.1  0.1  0.1  0.2
    Yes, but not in the last 12 months —  0.3  0.4  0.4  0.4 —  0.3  0.4  0.3  0.4 —  0.3  0.3  0.4  0.3
    No, never — 99.7 99.5 99.5 99.5 — 99.6 99.4 99.4 99.5 — 99.7 99.6 99.6 99.5
Weighted N = — 3,610 3,387 4,032 4,823 — 1,708 1,582 1,888 2,271 — 1,902 1,805 2,144 2,552
Source.   The Monitoring the Future study, the University of Michigan.
combined.    
“*” indicates a prevalence rate of less than 0.05%.
aData presented in this table are two-year moving averages. The 2005 data is 2004 and 2005 combined; the 2006 data is 2005 and 2006 combined; the 2007 data is a simple 
average of 2006 and 2007, because these questions were included in two questionnaire forms in 2006 and three forms beginning in 2007. The 2008 data is 2007 and 2008
TABLE 16
Trendsa in Injection Drug Use and Needle Sharing, 
Total and by Gender among Respondents of Modal Ages 21–30
(Entries are percentages.)
Total Male Female
Lifetime and Last 12 Months:
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2004 2005 2006 2007 2008 2004 2005 2006 2007 2008 2004 2005 2006 2007 2008
Number of Partners in Last 12 Months
During the LAST 12 MONTHS, how 
many sex partners have you had? 
(This includes vaginal, oral, or anal 
sex.)
    None — 14.5 14.6 13.7 13.5 — 16.9 16.6 14.7 14.3 — 12.3 12.8 12.7 12.8
    One — 61.2 61.5 61.9 62.2 — 56.3 56.2 57.0 58.6 — 65.6 66.1 66.2 65.3
    Two — 10.1  9.3  9.5  9.4 — 10.1  8.7  8.9  8.8 — 10.2  9.8 10.1 10.0
    Three —  5.9  6.2  5.8  5.9 —  6.1  7.5  7.2  6.4 —  5.6  5.1  4.5  5.4
    Four —  3.2  3.4  4.0  4.1 —  3.5  4.3  4.8  4.4 —  2.9  2.6  3.3  3.7
    5–10 —  3.9  4.1  4.2  4.0 —  5.2  5.3  5.8  5.5 —  2.7  3.0  2.8  2.6
    11–20 —  0.9  0.7  0.6  0.7 —  1.5  0.9  0.9  1.3 —  0.4  0.5  0.4  0.2
    21–100 —  0.2  0.2  0.2  0.3 —  0.4  0.4  0.5  0.5 —  0.1 * *  0.1
    More than 100 —  0.1  0.2  0.1  0.1 —  0.1  0.2  0.1  0.2 —  0.1  0.1 * *
Weighted N = — 3,628 3,432 4,066 4,844 — 1,720 1,611 1,902 2,276 — 1,908 1,821 2,163 2,568
Gender of Partners in Last 12 Months b
During the LAST 12 MONTHS, 
have your sex partner or partners 
been …
    Exclusively male? — 53.4 54.0 54.0 53.4 —  3.9  4.3  4.6  4.1 — 95.8 96.0 96.3 96.4
    Both male and female? —  1.5  1.4  1.4  1.3 —  1.0  0.8  1.0  0.9 —  1.9  1.9  1.7  1.7
    Exclusively female? — 45.1 44.6 44.6 45.3 — 95.0 94.9 94.4 95.0 —  2.3  2.1  2.0  1.9
Weighted N = — 3,103 2,935 3,504 4,180 — 1,432 1,344 1,616 1,950 — 1,672 1,590 1,888 2,230
Test for HIV: Lifetime and Last 12 Months
Have you ever been tested for 
HIV/AIDS? (Do not include tests 
that you may have had when 
donating blood or blood plasma.)
    Yes, in the last 12 months — 20.4 19.6 20.1 20.9 — 16.7 16.0 16.0 16.4 — 23.7 22.9 23.8 24.9
    Yes, but not in the last 12 — 24.0 23.9 23.5 22.9 — 21.2 20.8 21.2 20.7 — 26.5 26.6 25.5 24.8
    No, never — 55.7 56.5 56.4 56.2 — 62.2 63.2 62.8 62.9 — 49.8 50.6 50.7 50.3
Weighted N = — 3,664 3,459 4,098 4,882 — 1,738 1,629 1,919 2,293 — 1,927 1,830 2,179 2,589
Received HIV Test Resultsc
Did you receive the results of your 
most recent HIV/AIDS test? (We 
don ’t want to know your test 
results.)
    Yes — 92.2 92.8 92.5 92.7 — 89.8 91.2 92.2 92.0 — 93.9 93.8 92.7 93.2
    No —  7.8  7.2  7.5  7.3 — 10.2  8.8  7.8  8.0 —  6.1  6.2  7.3  6.8
Weighted N = — 1,610 1,486 1,764 2,113 — 655 591 701 842 — 955 895 1,063 1,271
cThose respondents who report never having been tested for HIV are excluded from these percentages. 
TABLE 17
Trendsa in Number of Partners, Gender of Partners, Test for HIV, and Received HIV Test Results: 
 Total and by Gender among Respondents of Modal Ages 21–30
(Entries are percentages.)
Total Male Female
bBased on those reporting sex with one or more partners during the past year. Those reporting no partners are omitted.
aData presented in this table are two-year moving averages. The 2005 data is 2004 and 2005 combined; the 2006 data is 2005 and 2006 combined; the 2007 data
is a simple  average of 2006 and 2007, because these questions were included in two questionnaire forms in 2006 and three forms beginning in 2007. 
The 2008 data is 2007 and 2008 combined.
Source.   The Monitoring the Future study, the University of Michigan.
“*” indicates a prevalence rate of less than 0.05%.
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2004 2005 2006 2007 2008 2004 2005 2006 2007 2008 2004 2005 2006 2007 2008
Blood Donation: Lifetime and Last 12 Months
Have you ever donated blood or blood 
plasma?
    Yes, in the last 12 months — 10.9 11.3 10.5 10.0 — 11.9 12.5 11.8 11.0 — 10.1 10.2  9.3  9.1
    Yes, but not in the last 12 months — 33.8 33.2 34.2 35.6 — 33.6 32.2 33.1 35.7 — 33.9 34.1 35.2 35.6
    No, never — 55.3 55.6 55.3 54.4 — 54.5 55.4 55.1 53.3 — 56.0 55.7 55.5 55.3
Weighted N = — 3,669 3,463 4,096 4,876 — 1,744 1,629 1,917 2,289 — 1,926 1,833 2,179 2,587
Frequency of Condom Use in Last 12 Monthsb
When you had sexual intercourse during the 
LAST 12 MONTHS, how often were 
condoms used? (This includes vaginal and 
anal sex, but not oral sex.)
    Never — 42.1 41.6 40.5 40.7 — 37.0 36.4 35.8 36.0 — 46.5 46.1 44.4 44.8
    Seldom — 13.7 13.2 13.6 13.2 — 13.7 12.8 13.3 13.8 — 13.7 13.5 13.7 12.6
    Sometimes — 12.4 13.3 13.5 13.0 — 12.8 13.0 13.3 13.2 — 12.0 13.5 13.7 12.8
    Most times — 15.5 15.2 15.2 14.9 — 17.8 18.0 16.8 15.7 — 13.5 12.9 13.9 14.3
    Always — 16.4 16.7 17.2 18.3 — 18.8 19.9 20.7 21.3 — 14.3 14.0 14.3 15.6
Weighted N = — 3,076 2,905 3,476 4,160 — 1,423 1,330 1,607 1,946 — 1,653 1,574 1,869 2,214
TABLE 18
Trendsa in Blood Donation and Frequency of Condom Use:
Total and by Gender among Respondents of Modal Ages 21–30
(Entries are percentages.)
Total Male Female
Source.   The Monitoring the Future study, the University of Michigan.
aData presented in this table are two-year moving averages. The 2005 data is 2004 and 2005 combined; the 2006 data is 2005 and 2006 combined; the 2007 data is a simple 
average of 2006 and 2007, because these questions were included in two questionnaire forms in 2006 and three forms beginning in 2007. The 2008 data is 2007 and 2008    
combined.
bPercentages based on those reporting sex with one or more partners during the last 12 months. Those reporting no partners are omitted.
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Figure 1
Trends* in Lifetime Injection Drug Use by Gender



































Source.   The Monitoring the Future study, the University of Michigan.
*Each point plotted here is the mean of the specified year and the previous year.


































in the Last 12 Months by Gender
Figure 2
Trends* in Having More than One Partner 
of the Same/Both Genders by Gendera

































Source.   The Monitoring the Future study, the University of Michigan.
*Each point plotted here is the mean of the specified year and the previous year.
aBased on those reporting sex with one or more partners during the past year. Those reporting no partners are omitted.


































Trends* in Annual Condom Use by Gendera
Trends* in Having an 































Source.   The Monitoring the Future study, the University of Michigan.
*Each point plotted here is the mean of the specified year and the previous year.
aBased on those reporting sex with one or more partners during the past year. Those reporting no partners are omitted.
bBased on those reporting having had an HIV/AIDS test in the last 12 months. Those respondents who have not been tested are omitted. 
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